Multiple Pathways, Multiple Targets: Drug Discovery For Celgene Trademark Details

Multiple Pathways, Multiple Targets: Drug Discovery for Celgene was registered on Tuesday, December 21, 2004 and is currently owned by Celgene Corporation under the registration number 2911994 . This mark is alive with a status of Registered and Renewed. The last case file activity for this mark occured 10 years ago on Monday, January 6, 2014, according to the United State Patent & Trademark Office
Word Mark Multiple Pathways, Multiple Targets: Drug Discovery for Celgene
Status Alive Registered 800 — Registered and Renewed

Current Owner

Celgene Corporation of Summit, NJ

View all trademarks for Celgene Corporation
Other Trademarks for Celgene Corporation
Serial Number 76413439
Registration Number 2911994
Status Date Monday, January 6, 2014
Filing Date Monday, January 6, 2014
Registration Date Tuesday, December 21, 2004
Attorney Camille M. Miller

Correspondent

Camille M. Miller
COZEN O'CONNOR
One Liberty Place
1650 MARKET ST
PHILADELPHIA PA 19103

Case File Statements

Disclaimer with Predetermined Text "Drug Discovery"
Goods & Services Research in the Fields of Chemicals and Pharmaceuticals; Scientific Research Services; Research and Testing Services in the Fields of Chemicals and Pharmaceuticals; Research and Development of New Products for Others in the Fields of Chemicals and Pharmaceuticals

Classifications

International Class Codes
042 — Class 42 includes mainly services provided by persons, individually or collectively, in relation to the theoretical and practical aspects of complex fields of activities; such services are provided by members of professions such as chemists, physicists, engineers, computer programmers, etc.
U.S. Class Codes 100, 101
Status 6 — Active
Status Date Tuesday, June 25, 2002
First Use Anywhere Saturday, May 18, 2002
First Use In Commerce Saturday, May 18, 2002
Primary Code 042

You must be signed in to print.

Once signed in, look for the PDF button.